Document Classification

Section Type: RESULTS

Text: Matched TA-TAVR patients experienced more adverse procedural events, longer length of stay (5 versus 8 days ; P < 0. 0001), and slower recovery (New York Heart Association class I, 31 % versus 38 % at 30 days, equalizing by 6 months at 51 % versus 47 %) ; stroke risk was similar (3. 4 % versus 3. 3 % at 30 days and 6. 0 % versus 6. 7 % at 3 years) ; mortality was elevated for the first 6 postprocedural months (19 % versus 12 % ; P = 0. 01) ; but aortic regurgitation was less (34 % versus 52 % mild and 8. 9 % versus 12 % moderate to severe at discharge, P = 0. 001 ; 36 % versus 50 % mild and 10 % versus 15 % moderate to severe at 6 months, P < 0. 0001).